• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.

作者信息

Scholz J, Schulz M, Steinfath M, Höver S, Bause H

机构信息

Department of Anesthesiology, University Hospital Eppendorf, Hamburg, Germany.

出版信息

J Mol Med (Berl). 1995 Mar;73(3):145-7. doi: 10.1007/BF00198243.

DOI:10.1007/BF00198243
PMID:7633952
Abstract

Fluconazole is effective for the treatment of fungal infections. A continuous venovenous hemofiltration (CVVH) was necessary in a liver transplant patient with anuria. Fluconazole treatment was started after the diagnosis of systemic candidiasis. There was no adverse effect on liver function, and the immunosuppression with cyclosporine was not affected. It is shown for the first time that CVVH effectively removes fluconazole from the blood circulation by a clearance into the hemofiltrate of approximately 21 ml/min. These data suggest that the treatment of fungal infections with fluconazole does not necessitate a reduction of the dosage during CVVH.

摘要

相似文献

1
Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
J Mol Med (Berl). 1995 Mar;73(3):145-7. doi: 10.1007/BF00198243.
2
Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.重症患者中观察到的与预测的抗菌药物持续静静脉血液滤过清除率之间的差异及其对给药的影响。
Intensive Care Med. 2006 Dec;32(12):2013-9. doi: 10.1007/s00134-006-0397-x. Epub 2006 Oct 17.
3
[Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)].
Mycoses. 1998;41 Suppl 2:86-8. doi: 10.1111/j.1439-0507.1998.tb00610.x.
4
Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.持续静脉-静脉血液透析滤过和持续静脉-静脉血液滤过对氟康唑药代动力学的影响。
Eur J Clin Pharmacol. 2000 Dec;56(9-10):671-8. doi: 10.1007/s002280000216.
5
Effective fluconazole therapy for liver transplant recipients during continuous hemodiafiltration.
Ther Drug Monit. 2001 Feb;23(1):4-8. doi: 10.1097/00007691-200102000-00002.
6
Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.接受持续静静脉血液滤过的病态肥胖重症患者的氟康唑药代动力学
Pharmacotherapy. 2014 Sep;34(9):e162-8. doi: 10.1002/phar.1470. Epub 2014 Jul 30.
7
Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure.
J Antimicrob Chemother. 1997 Nov;40(5):695-700. doi: 10.1093/jac/40.5.695.
8
Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.持续静静脉血液滤过和持续静静脉血液透析对万古霉素清除率的影响因素。
Am J Kidney Dis. 1998 Jun;31(6):1019-27. doi: 10.1053/ajkd.1998.v31.pm9631848.
9
Phenytoin removal by continuous venovenous hemofiltration.连续静脉-静脉血液滤过清除苯妥英钠。
Ann Pharmacother. 2013 Sep;47(9):1218-22. doi: 10.1177/1060028013503131.
10
Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD).
Mycoses. 1999 Apr;42(1-2):17-9. doi: 10.1046/j.1439-0507.1999.00269.x.

引用本文的文献

1
Unraveling the impact of renal impairment and renal replacement therapy modalities on fluconazole pharmacokinetics.解析肾功能损害及肾脏替代治疗方式对氟康唑药代动力学的影响。
Eur J Clin Pharmacol. 2025 Aug 11. doi: 10.1007/s00228-025-03901-y.
2
Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial.危重症患者持续静脉-静脉血液滤过期间抗感染药物的药代动力学和药效学:IVOIRE试验一项辅助研究的经验教训
J Transl Int Med. 2019 Dec 31;7(4):155-169. doi: 10.2478/jtim-2019-0031. eCollection 2019 Dec.
3

本文引用的文献

1
Oral azole drugs as systemic antifungal therapy.口服唑类药物作为全身性抗真菌治疗。
N Engl J Med. 1994 Jan 27;330(4):263-72. doi: 10.1056/NEJM199401273300407.
2
Ketoconazole, cyclosporin metabolism, and renal transplantation.
Lancet. 1982 Oct 16;2(8303):882-3. doi: 10.1016/s0140-6736(82)90851-0.
3
Removal of therapeutic drugs by continuous arteriovenous hemofiltration.通过连续性动静脉血液滤过清除治疗药物。
Arch Intern Med. 1985 Sep;145(9):1651-2.
Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.
间歇性血液透析和连续性肾脏替代治疗期间的药物剂量:儿科患者的特殊考量
Paediatr Drugs. 2004;6(1):45-65. doi: 10.2165/00148581-200406010-00004.
4
Absence of significant interaction of fluconazole with cyclosporin.氟康唑与环孢素之间不存在显著相互作用。
J Antimicrob Chemother. 1989 Nov;24(5):781-6. doi: 10.1093/jac/24.5.781.
5
Secondary mycosis in surgery: treatment with fluconazole.外科继发性真菌病:氟康唑治疗
Infection. 1989 Mar-Apr;17(2):111-7. doi: 10.1007/BF01646895.
6
Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.氟康唑在持续非卧床腹膜透析患者中的药代动力学。
Clin Pharmacokinet. 1990 Jun;18(6):491-8. doi: 10.2165/00003088-199018060-00006.
7
An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.肾功能损害及血液透析对氟康唑药代动力学影响的评估
Br J Clin Pharmacol. 1990 Feb;29(2):221-6. doi: 10.1111/j.1365-2125.1990.tb03623.x.
8
Rapid determination of serum levels of a new antifungal agent, fluconazole, by high-performance liquid chromatography.
J Chromatogr. 1990 Jul 13;529(1):223-8. doi: 10.1016/s0378-4347(00)83826-8.
9
Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.氟康唑。对其药效学和药代动力学特性以及在浅表和全身性真菌病中的治疗潜力的综述。
Drugs. 1990 Jun;39(6):877-916. doi: 10.2165/00003495-199039060-00006.
10
Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients.氟康唑用于治疗器官移植受者的侵袭性念珠菌和隐球菌感染。
Pharmacotherapy. 1990;10(6 ( Pt 3)):159S-163S.